| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/11/1999 | DE19729591A1 Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen Agents for the treatment and / or prophylaxis of microcirculation disorders |
| 02/11/1999 | DE19728737C1 Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten A method for the detection and determination of GnRH receptors and the use of GnRH agonists and GnRH-antagonists for the treatment of a tumor originating in the brain and / or nervous system and / or the meninges |
| 02/11/1999 | CA2298766A1 Human longevity-assurance protein homologs |
| 02/11/1999 | CA2298595A1 Process for converting propargylic amine-n-oxides to enaminones |
| 02/11/1999 | CA2298573A1 Synaptojanin isoform |
| 02/11/1999 | CA2298506A1 Methods for treating neurological deficits |
| 02/11/1999 | CA2297490A1 Method enabling readministration of aav vector via immunosuppression of host |
| 02/11/1999 | CA2290748A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2244801A1 Suppressory agents against hypercoagulation |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/10/1999 | EP0896061A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896060A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0895780A1 Extended release tablets particularly containing pseudoephedrine hydrochloride |
| 02/10/1999 | CN1207685A Novel medical use of ACE-inhibitor for treatment of dyspeptic symptoms |
| 02/10/1999 | CN1207679A Use of cholinesterase inhibitors in treatment of xerostomia |
| 02/09/1999 | US5869610 Isolated polypeptide identified as a cytokine receptor containing extracellular, transmembrane and intracellular domains; prenatal testing and cancer diagnosis |
| 02/09/1999 | US5869534 Administering aminoguanidine and analogs thereof to reduce lipid oxidation and inhibit an increase in serum low density lipoproteins to prevent disease states characterized by the presence of advanced glycosylation endproducts |
| 02/09/1999 | US5869522 Solvent extraction; plant extracts; trimerization of 2,3-deoxy-1,4-naphthoquinone |
| 02/09/1999 | US5869498 Pain alleviating drug composition and method for alleviating pain |
| 02/09/1999 | US5869479 Administering histamine h1 receptor antagonists and histamine h3 receptor antagonists; nasal decongestant without the nervous system or cardiovascular side effects |
| 02/09/1999 | US5869471 Methods for the treatment of arthritis using phosphonates and NSAIDS |
| 02/09/1999 | US5869324 Chiral resolution by contacting mixture with enzyme and acylating agent, separating esterified calanolide a |
| 02/09/1999 | US5869290 Cayae1 polynucleotides |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/09/1999 | US5869230 Gene transfer into the kidney |
| 02/09/1999 | US5869098 Includes at least one flowable, partially crystallized amorphous matrix comprising carbohydrate(s) and sugar alcohol(s) and a tableting aid with a bio-affecting agent |
| 02/09/1999 | US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis |
| 02/08/1999 | CA2239223A1 Novel rpoa |
| 02/08/1999 | CA2239222A1 Novel rpoa |
| 02/06/1999 | CA2239256A1 Novel lgt |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/05/1999 | CA2239270A1 Novel phosphoribosyl transferase |
| 02/05/1999 | CA2238673A1 Novel aminopeptidase |
| 02/04/1999 | WO1999005299A1 Methods of using cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy |
| 02/04/1999 | WO1999005291A2 Aggrecan degrading metallo proteases |
| 02/04/1999 | WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS |
| 02/04/1999 | WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 02/04/1999 | WO1999004820A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 02/04/1999 | WO1999004817A1 Chemotherapy synergistic agent |
| 02/04/1999 | WO1999004816A1 Proton pump inhibitor in therapeutic combination with antibacterial substances |
| 02/04/1999 | WO1999004813A1 Receptor specific transepithelial transport of therapeutics |
| 02/04/1999 | WO1999004809A1 Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections |
| 02/04/1999 | WO1999004795A1 Delta opioid receptor agonist for reducing ischemic damage |
| 02/04/1999 | WO1999004775A2 Method of treating dopaminergic and gaba-nergic disorders |
| 02/04/1999 | WO1999004773A2 Method for inhibiting bone resorption |
| 02/04/1999 | WO1999004752A2 Methods for treating skin pigmentation |
| 02/04/1999 | WO1998050424A3 Human serine protease precursor |
| 02/04/1999 | CA2298053A1 Novel estrogen receptor .beta. and isoforms |
| 02/04/1999 | CA2297907A1 Human estrogen receptor beta |
| 02/04/1999 | CA2297410A1 Method of treating dopaminergic and gaba-nergic disorders |
| 02/04/1999 | CA2297251A1 Delta opioid receptor agonist for reducing ischemic damage |
| 02/04/1999 | CA2296798A1 Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents |
| 02/04/1999 | CA2267077A1 Methods for treating skin pigmentation |
| 02/04/1999 | CA2239267A1 Novel compounds |
| 02/03/1999 | EP0894862A2 Novel CysS |
| 02/03/1999 | EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894859A2 Asparaginyl tRNA synthetase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894858A2 Prolyl tRNA synthetase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894857A2 SecA gene from Streptococcus pneumoniae |
| 02/03/1999 | EP0894856A1 A human sMAD3 splice variant |
| 02/03/1999 | EP0894855A2 Human I kappa B-beta transcription factor |
| 02/03/1999 | EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor |
| 02/03/1999 | EP0894806A1 Novel pheS |
| 02/03/1999 | EP0894269A1 Tfiib transcription factor from candida albicans |
| 02/03/1999 | EP0894139A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 02/03/1999 | EP0894133A2 Neuropeptide y receptor y5 and nucleic acid sequence |
| 02/03/1999 | EP0894130A1 Modulators of tnf receptor associated factor (traf), their preparation and use |
| 02/03/1999 | EP0894009A1 Improved vision through photodynamic therapy of the eye |
| 02/03/1999 | EP0894006A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE THREONYL tRNA SYNTHETASE FAMILY |
| 02/03/1999 | EP0699202B1 Calanolide and related antiviral compounds, compositions, and uses thereof |
| 02/03/1999 | EP0510186B1 Therapeutic uses of melanin |
| 02/03/1999 | CN1207045A Nisin in combination with glycerol monolaurate active against helicobacter |
| 02/03/1999 | CN1207042A A Pharmaceutical composition for the treatment of autommune diseases |
| 02/02/1999 | US5866679 Peptides |
| 02/02/1999 | US5866617 Aqueous solution for administration to patients also receiving cisplatin; reduced side effects, increased antitumor activity |
| 02/02/1999 | US5866615 Lyophilized formulation with anticancer agents; reduced side effects, increased activity |
| 02/02/1999 | US5866605 Method for providing a neuroprotective effect to the mammalian eye by administration of chloride channel blockers |
| 02/02/1999 | US5866584 Administration of a dopamine agonist, over a limited period at a time of day dependent on the normal circadian rhythm of insulin resistant and insulin sensitive members of a similar species. |
| 02/02/1999 | US5866554 Drug mixture of hyaluronic acid, non-steroidal inflammatory drug and acid salt |
| 02/02/1999 | US5866547 Methods of neuroendocrine regulation of affective disorders |
| 02/02/1999 | US5866546 Administering immunoregulator and cell proliferative agent |
| 02/02/1999 | US5866536 Compounds and compositions for delivering active agents |
| 02/02/1999 | US5866418 Filtration; ion exchanging; ulcers, gastrointestinal disorders |
| 02/02/1999 | US5866390 Leucyl tRNA synthetase polynucleotides of streptococcus |
| 02/02/1999 | US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.? |
| 02/02/1999 | US5866366 gidB |
| 02/02/1999 | US5866365 Utilizing rnc polypeptides to screen for antibacterial compounds. |
| 02/02/1999 | US5866169 Lyophilized formulation with cisplatin; reduced side effects, increased antitumor activity |
| 02/02/1999 | US5866164 Composition and dosage form comprising opioid antagonist |
| 02/02/1999 | US5866159 Pharmaceutical compositions comprising cyclosporins |
| 02/02/1999 | US5866122 Using prothrombinase |
| 02/02/1999 | CA2130464C Topical aromatic releasing compositions |
| 02/02/1999 | CA2061917C Pediatric effervescent dosage form |
| 02/02/1999 | CA2053275C Fibroblast growth factor conjugates |
| 02/01/1999 | CA2238672A1 Seca |
| 02/01/1999 | CA2238670A1 A novel smad3 splice variant as a target in chronic renal failure, atherosclerosis and fibrosis |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |
| 01/28/1999 | WO1999004265A2 Cancer associated nucleic acids and polypeptides |
| 01/28/1999 | WO1999004040A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |